13F Pro Quality Score

31.0/100

Rank #2,332 of 2,879 stocks

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

14.0/100

Profitability

46.2/100

Balance Sheet

25.7/100

Earnings Quality

30.0/100

Free Cash Flow

26.7/100

Institutional Flow

39.5/100

Revenue Scale

21.6/100

Dilution Risk

86.8/100

HHS Stock Analysis & AI Quality Score

AI stock analysis and institutional research for HARTE HANKS INC (HHS), a Industrials sector company. 13F Pro's AI-powered ranking engine scores HHS at 31.0/100 on a 32-signal composite quality model, placing it at rank #2,332 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (14.0) and revenue scale (21.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), HARTE HANKS INC reports quarterly revenue of $37.3M, net income of $-628.0K, an operating margin of -2.1%. Top institutional holders of HHS by reported 13-F value include BLAIR WILLIAM & CO/IL, WESTERLY CAPITAL MANAGEMENT,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. HHS trades on the Nasdaq exchange and files with the SEC under CIK 45919. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HHS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HARTE HANKS INC directly from SEC EDGAR. HARTE HANKS INC's 13F Pro composite quality score has ranged between 19 and 55 since 2022, currently 31.0 — a declining long-term trajectory across 22 quarterly and live scoring snapshots.

Fun facts about HARTE HANKS INC

Quirks, history, and lore behind HHS — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    A B2B services company · small-cap · listed on NYSE American · headquartered in Texas.
  • 2
    The Numbers
    Annual revenue in the range of a few hundred million dollars, with a workforce that has shrunk considerably over the decades as the industry shifted digital.
  • 3
    The History
    Founded in the 1960s, it built its name in direct mail and database marketing back when a stuffed mailbox was the cutting edge of customer outreach.
  • 4
    The Secret
    It pivoted hard into customer experience management — think contact centers, fulfillment, and data analytics — trying to stay relevant as physical mail became a punchline.
  • 5
    The Lore
    For decades it ran one of the largest direct-mail databases in the U.S., helping brands reach millions of households with the kind of targeted data that Facebook would later make look quaint.
  • 6
    The Giveaway
    Its name pairs a Texas newspaper dynasty surname with a classic marketing services word — a legacy combo that screams old-school direct response advertising.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$37.3M

Net Income

Q1 2026

$-628.0K

Free Cash Flow

Q1 2026

$-922.0K

Operating Margin

Q1 2026

-2.1%

ROIC

Q1 2026

-3.8%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-13.9% YoY
$159.6MFY 2025
FY19 $217.6MFY21 $194.6MFY24 $185.2MFY25 $159.6M

Net Income

+97.3% YoY
$-811.0KFY 2025
FY19 $-26.3MFY21 $15.0MFY24 $-30.3MFY25 $-811.0K

Operating Income

-81.6% YoY
$386.0KFY 2025
FY19 $-21.6MFY21 $7.6MFY24 $2.1MFY25 $386.0K

EPS (Diluted)

+97.3% YoY
$-0.11FY 2025
FY19 $-4.26FY21 $1.76FY24 $-4.15FY25 $-0.11

Total Assets

-9.8% YoY
$91.8MFY 2025
FY19 $110.2MFY21 $107.9MFY24 $101.8MFY25 $91.8M

Total Debt

FY 2025
FY19 $18.7MFY21 $5.0MFY24 FY25

Op. Cash Flow

+41.9% YoY
$-1.7MFY 2025
FY19 $12.1MFY21 $-1.8MFY24 $-3.0MFY25 $-1.7M

AI Insight: HHS Financial Trends

Harte Hanks faces persistent revenue contraction with operating performance near breakeven despite stabilized equity.

Revenue declined 18% from $45M in Q2 2024 to $37M in Q1 2026, with every quarter showing year-over-year deterioration.

Operating income swung wildly between -$2M and $2M; latest quarter at -$1M signals continued structural profitability challenges.

Operating cash flow highly volatile (ranging -$5M to +$4M) with Q1 2026 at -$1M; no sustained positive conversion.

Revenue stabilized at $40M in Q4 2025 but fell again to $37M in Q1 2026, suggesting near-term floor not yet reached.

Equity held steady around $20–22M despite cumulative operating losses; debt figures unavailable limits leverage assessment.

AI Insight: HHS Ratio Trends

Harte Hanks deteriorated sharply into Q1 2026, with negative operating margins, collapsing ROIC to -15.3%, and profitability eroding across all return metrics.

Operating margin turned -2.1% in Q1 2026, worst since Q4 2024's -3.3%, after near-breakeven Q4 2025.

ROIC collapsed from 10.2% in Q3 2025 to -15.3% in Q1 2026, erasing two quarters of recovery.

Net profit margin swung from +5.5% in Q4 2025 to -1.7% in Q1 2026, reversing sole quarterly profit.

TTM results deeply negative across OpMargin (-0.2%), NPM (-0.7%), ROE (-5.2%), ROA (-1.2%), ROIC (-1.7%).

Q1 2026 marks third consecutive quarter of negative ROIC; pattern suggests structural headwinds, not seasonality.

Get alerted when HHS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for HARTE HANKS INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put HHS on your watchlist

Track score changes the day HARTE HANKS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is HHS a good stock to buy?

13F Pro's AI-powered analysis of HARTE HANKS INC (HHS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HHS are available on the HHS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own HHS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HHS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HARTE HANKS INC's investment landscape.